Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q74650216)
Watch
English
Suramin treatment in hormone- and chemotherapy-refractory prostate cancer
scientific article published on 01 March 1999
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
title
Suramin treatment in hormone- and chemotherapy-refractory prostate cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
main subject
chemotherapy
1 reference
based on heuristic
inferred from title
prostate cancer
1 reference
based on heuristic
inferred from title
suramin
1 reference
based on heuristic
inferred from title
author name string
J M Garcia-Schürmann
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
H Schulze
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
G Haupt
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
J Pastor
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
B Allolio
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
T Senge
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
language of work or name
English
0 references
publication date
1 March 1999
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
published in
Urology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
volume
53
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
issue
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
page(s)
535-541
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
cites work
Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suramin in adrenocortical cancer: limited efficacy and serious toxicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suramin, an active drug for prostate cancer: interim observations in a phase I trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suramin: an anticancer drug with a unique mechanism of action.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synergistic activity of suramin with tumor necrosis factor alpha and doxorubicin on human prostate cancer cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suramin Keratopathy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development and validation of a pharmacokinetically based fixed dosing scheme for suramin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I study of suramin given by intermittent infusion without adaptive control in patients with advanced cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900544-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0090-4295(98)00544-5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
PubMed publication ID
10096380
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10096380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10096380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
